CMV prophylaxis: what is valid in 2002?

被引：4

作者：

Heemann, U ^{[1
]}

Wenzel, RR ^{[1
]}

机构：

[1] Essen Univ Hosp, Dept Nephrol, D-45122 Essen, Germany

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2002年 / 17卷 / 04期

关键词：

D O I：

10.1093/ndt/17.4.556

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

In summary, CMV should be considered in all cases of diarrhoea, creatinine increase, and/or leucopenia. In these cases and/or on a regular basis early markers for CMV should be tested and pre-emptive therapy initiated if tests give a positive result for as long as tests are positive.

引用

收藏

页码：556 / 559

页数：4

相关论文

共 19 条

[1]

[Anonymous], 2000, COCHRANE DATABASE SY

[2] Cytomegalovirus infection and graft rejection in renal transplantation [J].

Dickenmann, MJ ;

Cathomas, G ;

Steiger, J ;

Mihatsch, MJ ;

Thiel, G ;

Tamm, M .

TRANSPLANTATION, 2001, 71 (06) :764-767

[3] Preemptive treatment for the prevention of cytomegalovirus disease - In lung and heart transplant recipients [J].

Egan, JJ ;

Lomax, J ;

Barber, L ;

Lok, SS ;

Martyszczuk, R ;

Yonan, N ;

Fox, A ;

Deiraniya, AK ;

Turner, AJ ;

Woodcock, AA .

TRANSPLANTATION, 1998, 65 (05) :747-752

[4] Relationship between IgM antibody to human cytomegalovirus, virus load, donor and recipient serostatus, and administration of methylprednisolone as risk factors for cytomegalovirus disease after liver transplantation [J].

Emery, VC ;

Cope, AV ;

Sabin, CA ;

Burroughs, AK ;

Rolles, K ;

Lazzarotto, T ;

Landini, MP ;

Brojanac, S ;

Wise, J ;

Maine, GT .

JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06) :1610-1615

[5] Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy [J].

Emery, VC ;

Griffiths, PD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (14) :8039-8044

[6]

FIETZE E, 1994, TRANSPLANTATION, V58, P675

[7] Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection [J].

Hengster, P ;

Pescovitz, MD ;

Hyatt, D ;

Margreiter, R .

TRANSPLANTATION, 1999, 68 (02) :310-313

[8]

Hibberd P L, 1993, Semin Respir Infect, V8, P216

[9] Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients [J].

Humar, A ;

Gillingham, KJ ;

Payne, WD ;

Dunn, DL ;

Sutherland, DER ;

Matas, AJ .

TRANSPLANTATION, 1999, 68 (12) :1879-1883

[10] Long-term oral ganciclovir prophylaxis for prevention of cytomegalovirus infection and disease in cytomegalovirus high-risk renal transplant recipients [J].

Kletzmayr, J ;

Kreuzwieser, E ;

Watkins-Riedel, T ;

Berlakovich, G ;

Kovarik, J ;

Klauser, R .

TRANSPLANTATION, 2000, 70 (08) :1174-1180